Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms

por Yamaoka, Toshimitsu, Ohba, Motoi, Ohmori, Tohru
Publicado 2017

HER2-D16 oncogenic driver mutation confers osimertinib resistance in EGFR mutation-positive non-small cell lung cancer

por Yamaoka, Toshimitsu, Tsurutani, Junji, Sagara, Hironori, Ohmori, Tohru
Publicado 2020

Up-regulation of Syndecan-4 contributes to TGF-β1-induced epithelial to mesenchymal transition in lung adenocarcinoma A549 cells

por Toba-Ichihashi, Yoko, Yamaoka, Toshimitsu, Ohmori, Tohru, Ohba, Motoi
Publicado 2015

Receptor Tyrosine Kinase-Targeted Cancer Therapy

por Yamaoka, Toshimitsu, Kusumoto, Sojiro, Ando, Koichi, Ohba, Motoi, Ohmori, Tohru
Publicado 2018

Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury

por Ohmori, Tohru, Yamaoka, Toshimitsu, Ando, Koichi, Kusumoto, Sojiro, Kishino, Yasunari, Manabe, Ryou, Sagara, Hironori
Publicado 2021

Comparative Efficacy and Safety of Lorlatinib and Alectinib for ALK-Rearrangement Positive Advanced Non-Small Cell Lung Cancer in Asian and Non-Asian Patients: A Systematic Review...

por Ando, Koichi, Manabe, Ryo, Kishino, Yasunari, Kusumoto, Sojiro, Yamaoka, Toshimitsu, Tanaka, Akihiko, Ohmori, Tohru, Sagara, Hironori
Publicado 2021

Comparative Efficacy of ALK Inhibitors for Treatment-Naïve ALK-Positive Advanced Non-Small Cell Lung Cancer with Central Nervous System Metastasis: A Network Meta-Analysis

por Ando, Koichi, Manabe, Ryo, Kishino, Yasunari, Kusumoto, Sojiro, Yamaoka, Toshimitsu, Tanaka, Akihiko, Ohmori, Tohru, Sagara, Hironori
Publicado 2023

Nivolumab plus Ipilimumab versus Existing Immunotherapies in Patients with PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

por Ando, Koichi, Kishino, Yasunari, Homma, Tetsuya, Kusumoto, Sojiro, Yamaoka, Toshimitsu, Tanaka, Akihiko, Ohmori, Tohru, Ohnishi, Tsukasa, Sagara, Hironori
Publicado 2020

Comparative Efficacy and Safety of Anti-PD-1/PD-L1 Immune Checkpoint Inhibitors for Refractory or Relapsed Advanced Non-Small-Cell Lung Cancer—A Systematic Review and Network Meta-...

por Ando, Koichi, Manabe, Ryo, Kishino, Yasunari, Kusumoto, Sojiro, Yamaoka, Toshimitsu, Tanaka, Akihiko, Ohmori, Tohru, Ohnishi, Tsukasa, Sagara, Hironori
Publicado 2020

Novel Anti-FOLR1 Antibody–Drug Conjugate MORAb-202 in Breast Cancer and Non-Small Cell Lung Cancer Cells

por Matsunaga, Yuki, Yamaoka, Toshimitsu, Ohba, Motoi, Miura, Sakiko, Masuda, Hiroko, Sangai, Takafumi, Takimoto, Masafumi, Nakamura, Seigo, Tsurutani, Junji
Publicado 2021

Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previously Untreated Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Ne...

por Ando, Koichi, Manabe, Ryo, Kishino, Yasunari, Kusumoto, Sojiro, Yamaoka, Toshimitsu, Tanaka, Akihiko, Ohmori, Tohru, Ohnishi, Tsukasa, Sagara, Hironori
Publicado 2021

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

por Oki, Yasunari, Hirose, Takashi, Yamaoka, Toshimitsu, Kusumoto, Sojiro, Shirai, Takao, Sugiyama, Tomohide, Okuda, Kentaro, Nakashima, Masanao, Murata, Yasunori, Ohmori, Tohru, Adachi, Mitsuru
Publicado 2010

Brigatinib and Alectinib for ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer with or without Central Nervous System Metastasis: A Systematic Review and Network Meta-...

por Ando, Koichi, Akimoto, Kaho, Sato, Hiroki, Manabe, Ryo, Kishino, Yasunari, Homma, Tetsuya, Kusumoto, Sojiro, Yamaoka, Toshimitsu, Tanaka, Akihiko, Ohmori, Tohru, Sagara, Hironori
Publicado 2020

Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR-Activating Mutation

por Nishihara, Shigetoshi, Yamaoka, Toshimitsu, Ishikawa, Fumihiro, Ohmori, Tohru, Ando, Koichi, Kusumoto, Sojiro, Kishino, Yasunari, Manabe, Ryo, Hasebe, Yuki, Sagara, Hironori, Yoshida, Hitoshi, Tsurutani, Junji
Publicado 2022

Blockade of EGFR Activation Promotes TNF-Induced Lung Epithelial Cell Apoptosis and Pulmonary Injury

por Yamaoka, Toshimitsu, Arata, Satoru, Homma, Mayumi, Homma, Tetsuya, Kusumoto, Sojiro, Ando, Koichi, Manabe, Ryou, Kishino, Yasunari, Ohba, Motoi, Tsurutani, Junji, Takimoto, Masafumi, Ohmori, Tohru, Sagara, Hironori
Publicado 2019

Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer

por Nishihara, Shigetoshi, Yamaoka, Toshimitsu, Ishikawa, Fumihiro, Higuchi, Kensuke, Hasebe, Yuki, Manabe, Ryo, Kishino, Yasunari, Kusumoto, Sojiro, Ando, Koichi, Kuroda, Yusuke, Ohmori, Tohru, Sagara, Hironori, Yoshida, Hitoshi, Tsurutani, Junji
Publicado 2022

Inhibition of Virus-Induced Cytokine Production from Airway Epithelial Cells by the Late Addition of Budesonide

por Homma, Tetsuya, Fukuda, Yosuke, Uchida, Yoshitaka, Uno, Tomoki, Jinno, Megumi, Kishino, Yasunari, Yamamoto, Mayumi, Sato, Hiroki, Akimoto, Kaho, Kaneko, Keisuke, Fujiwara, Akiko, Sato, Haruna, Hirai, Kuniaki, Miyata, Yoshito, Inoue, Hideki, Ohta, Shin, Watanabe, Yoshio, Kusumoto, Sojiro, Ando, Koichi, Suzuki, Shintaro, Yamaoka, Toshimitsu, Tanaka, Akihiko, Ohmori, Tohru, Sagara, Hironori
Publicado 2020